The Actual Challenges of Biologics Treatment in Patients with Psoriasis
The article contain the main challenges meet doctors in real practice using biologics for treatment patients with psoriasis.Different aspects and concerns have been analised from new point of view: the aims of Bx therapy (incl. control of remission, personalized goals, etc.) primary and secondary re...
Saved in:
Main Author: | Andrey L. Bakulev (Author) |
---|---|
Format: | Book |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis
by: A. L. Bakulev
Published: (2019) -
Strategy "treat to target" for patients with psoriasis. Relevant issues to biological therapy persistence
by: A. L. Bakulev
Published: (2017) -
Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab
by: Andrey L. Bakulev, et al.
Published: (2022) -
Psoriasis in Pediatrics
by: Andrey L. Bakulev, et al.
Published: (2020) -
Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients
by: A. L. Bakulev
Published: (2017)